Open AccessEfficacy of Shenmai injection for the treatment of chronic heart failure
Author(s) -
Peng Gao,
Xian Wu,
Zhang Fu-hua,
Zhi-li Qiao,
Luting Yang
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000020663
Subject(s) - medicine , medline , cochrane library , data extraction , scopus , heart failure , meta analysis , randomized controlled trial , web of science , intensive care medicine , political science , law
Background: This study will assess the efficacy and safety of Shenmai injection (SMI) for the treatment of chronic heart failure (CHF). Methods: The following electronic bibliographic databases will be searched from inception to the March 25, 2020 without language and publication time limitations: MEDLINE, PUBMED, Cochrane Library, Web of Science, Scopus, WANGFANG, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure. All randomized controlled trials related to the SMI for patients with CHF will be included. All study selection, data extraction, and study quality will be carried out by 2 reviewers. Any disagreements will be solved by a third reviewer through discussion. RevMan 5.3 software will be used for data synthesis and data analysis. Results: This study will summarize the present evidence of SMI for the treatment of patients with CHF. Conclusion: The findings of this study will determine whether SMI is effective and safety for the treatment of CHF or not. Study registration number: INPLASY202050029.